Sign Up to like & get
recommendations!
1
Published in 2022 at "Circulation"
DOI: 10.1161/circulationaha.122.062132
Abstract: Background: VERVE-101 is an investigational in vivo CRISPR base-editing medicine designed to alter a single DNA base in the PCSK9 gene, permanently turn off hepatic protein production, and thereby durably lower low-density lipoprotein cholesterol. We…
read more here.
Keywords:
verve;
verve 101;
pcsk9;
crispr base ... See more keywords